Skip to content

ImPACT Quick Test

by ImPACT Applications, Inc.

510(k) K170551

Active European Union and United States

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK170551 Date21 Jun 2017ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
24 Feb 2017
FDA decision
21 Jun 2017 (Substantially Equivalent)
FDA review time
117 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K170551 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K170551 decided 21 Jun 2017 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
POM
Device class
Class II
Regulation
21 CFR Part 882.1471
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The ImPACT Quick Test is a Computerized Cognitive Assessment Aid for Concussion, designed to evaluate cognitive function in patients suspected of having a concussion or mild traumatic brain injury. It provides standardized assessments of verbal and visual memory, processing speed, reaction time, and other neurocognitive domains to aid in clinical decision-making and monitoring of recovery progress.

This device is supplied as a software application for use on compatible computers and is intended for single-use per patient assessment. It operates in clinical settings such as emergency departments, sports medicine facilities, and neurology clinics, with no sterility requirements. The ImPACT Quick Test holds FDA 510(k) clearance and is classified under EU MDR, adhering to regulatory standards for cognitive assessment tools in concussion management.

Devices cleared under K170551

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K170551
UDI-DISize and differences
ImPACT Quick Test 1
ImPACT Applications, Inc.
100864127000325 —No longer on the market
ImPACT Quick Test 2
ImPACT Applications, Inc.
200864127000356 —On the market

Similar devices

Other devices filed under FDA product code POM (Computerized Cognitive Assessment Aid For Concussion).

Other devices from ImPACT Applications, Inc.

See all devices from ImPACT Applications, Inc. →